🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06848036
Active, not recruiting Not applicable

Effectiveness of a Smart Community- and Home-based Integrated Care Services System for Elderly People

NCT06848036 · tracked via the Priya Life Science China tracker
Sponsor
Liu Zhihan
Phase
Not applicable
Started
2024-08-07
Last updated
2025-02-26

Condition(s) studied

Smart Community- and Home-based Integrated Care Services

Investigational drug(s) / intervention(s)

smart integrated care services

smart integrated care services: Provide integrated care services through the 'Hunan Province Integrated Healthcare and Elderly Care Intelligent Service Platform,' including home-based care, mobile medical visits, and remote diagnosis and treatment services."

Study summary

In recent years, the widespread application of emerging information technologies such as artificial intelligence, the Internet of Things, big data, cloud computing, and 5G has made "smart " a new breakthrough in the integrated healthcare and elderly care model. Smart Community- and Home-based Integrated Care Services , utilizing methods such as home hospital beds and mobile medical visits, ensure that key elderly groups with disabilities, dementia, chronic diseases, advanced age, and disabilities can receive the necessary medical services at home. This not only allows the elderly to live in familiar home environments, maintaining their independence and dignity, but also alleviates the pressure on medical resources, enabling more resources to be allocated to emergency care and highly specialized nursing. However, the smart healthcare and elderly care platform model is still in the pilot stage and requires more scientific evidence to verify its actual impact on the health of the elderly.

The purpose: The purpose of this clinical trial is to understand and verify the potential health improvement effects of the smart healthcare and elderly care platform on the elderly. By collecting health indicator data at different time points before and after the intervention, the study will compare the differences in health indicators between community-dwelling elderly who have used the smart healthcare and elderly care platform and those who have not, providing scientific evidence for the promotion of the smart healthcare and elderly care platform model and further facilitating its application and popularization among the elderly in the community.

The main question it aims to answer is: Are community-dwelling elderly who use the smart healthcare and elderly care platform healthier than those who do not use the service? Participants will: Participants will be randomly divided into an experimental group and a control group. The elderly in the experimental group will use the "Hunan Province Integrated Healthcare and Elderly Care Intelligent Service Platform," while the control group will not use the platform for blank control.

Data collection: The research team will collect health indicator data four times, including SF-36, Activities of Daily Living (ADL), and the Geriatric Depression Scale (GDS), at baseline, 3 months post-intervention, 6 months post-intervention, and 12 months post-intervention.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Participants aged ≥60 years 2. Normal verbal communication abilities 3. No self-reported visual or auditory impairments 4. Presence of a long-term, fixed caregiver who accompanies and lives with the participant 5. Both the participant and their family members are informed and consent voluntarily to participate in this study Exclusion Criteria 1. Participants aged \<60 years 2. Individuals suffering from severe physical or mental illnesses 3. Elderly individuals who have participated in other similar studies within the past year 4. Elderly individuals residing in institutions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Changsha County Guoyuan Town Health Center Changsha Hunan
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06848036 on ClinicalTrials.gov ↗ ← All trials in China